Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase NA 1Phase 1 1

Status

Recruiting 2Completed 2Withdrawn 1Terminated 1

Sponsor Class

OTHER 140NIH 9NETWORK 6INDUSTRY 6OTHER_GOV 5

Study Type

Interventional 6

Sponsor

Cancer Type

Breast 6Thoracic 5Gastrointestinal 4Plasma cell 2Genitourinary 2Other hematologic neoplasm 1Lymphoid 1Head & Neck 1Gynecologic 1Classical hematology 1

Conditions

Breast Neoplasms 2551Triple Negative Breast Neoplasms 436Carcinoma, Non-Small-Cell Lung 339Ovarian Neoplasms 315Neoplasms 281Neoplasm Metastasis 253Colorectal Neoplasms 246Stomach Neoplasms 202Pancreatic Neoplasms 196Prostatic Neoplasms 188Lung Neoplasms 180Melanoma 171Squamous Cell Carcinoma of Head and Neck 140Endometrial Neoplasms 140Head and Neck Neoplasms 124Carcinoma, Renal Cell 118Uterine Cervical Neoplasms 104Esophageal Neoplasms 97Urinary Bladder Neoplasms 92Small Cell Lung Carcinoma 87Sarcoma 85Colonic Neoplasms 80Carcinoma, Hepatocellular 62Carcinoma, Transitional Cell 61Kidney Neoplasms 51Advanced Breast Cancer 51Cholangiocarcinoma 50Liver Neoplasms 47Brain Neoplasms 43Mesothelioma 37

Interventions

reparixin 1Walking 1Saline Solution 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
INDUSTRY × Fatigue × Breast × Clear all
NCT06137833 2025-10-01

Wide Spectrum Micronutrients Supplementation in Patients With Cancer Related Fatigue During Neoadjuvant and Adjuvant Chemotherapy

Pharmanutra S.p.a.

Phase NA Recruiting
92 enrolled
Breast

Breast Neoplasms, Fatigue

NCT05440227 2025-06-05

PG2 Injection for the Treatment of moderate-to Severe Fatigue in Breast Cancer Patients

PhytoHealth Corporation

Phase 2 Recruiting
36 enrolled
Breast

Breast Neoplasms, Fatigue

NCT05212701 2024-04-30

To Assess Efficacy and Safety of Oral Reparixin in Patients With Fatigue and Locally Advanced / Metastatic Breast Cancer

Dompé Farmaceutici S.p.A

Phase 2 Withdrawn
Breast

Breast Neoplasms, Fatigue

NCT04803305 2024-01-12

Study to Compare the Effects of Repeated Doses of an Investigational New Drug and a Placebo on Appetite in Advanced Cancer and Anorexia

Pfizer

Phase 1 Completed
18 enrolled 14 charts
BreastGastrointestinalGenitourinaryGynecologicThoracic

Anorexia, Breast Neoplasms, Cachexia, Carcinoma, Non-Small-Cell Lung, Fatigue, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Colorectal Neoplasms, Weight Loss

NCT02434367 2017-12-14

WWE

The West Clinic, Memphis

Phase 2 Completed
50 enrolled
Breast

Breast Neoplasms, Fatigue, Neoplasms

NCT02645175 2016-10-21

Evaluate the Safety Profile and Ability of TW1025 Oral Solution to Decrease Fatigue

Meriyana Bio Inc.

Phase 2 Terminated
3 enrolled
Breast

Breast Neoplasms, Fatigue

Data powered by HemOnc (CC BY 4.0) Colophon âš¡